(Q35592697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

The relation between c-myc expression and interferon sensitivity in uveal melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

George D Wilson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

P N Tulley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M Neale

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

D Jackson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J S Chana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

R Grover

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

I Cree

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Ophthalmology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1563-1567

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

Critical appraisal of IFN-alpha-based adjuvant therapy in stage II-III malignant melanoma

5 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

HLA expression in uveal melanoma: there is no rule without some exception

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

An update on adjuvant interferon for melanoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Association of HLA class I and class II antigen expression and mortality in uveal melanoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Uveal melanoma: natural history and treatment options for metastatic disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Heterogeneity of chemosensitivity of metastatic cutaneous melanoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

The clinical significance of c-myc oncogene expression in melanomas of the scalp

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Type I interferon induction of the Cdk-inhibitor p21WAF1 is accompanied by ordered G1 arrest, differentiation and apoptosis of the Daudi B-cell line

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

HLA expression in a primary uveal melanoma, its cell line, and four of its metastases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Comparison of MTT and ATP-based assays for the measurement of viable cell number

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Effects of interferon alfa and gamma on human uveal melanoma cells in vitro

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

c-myc down-regulates class I HLA expression in human melanomas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Transfection of fibroblasts with activated c-myc confers resistance to antigrowth effects of interferon.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

MHC antigens in human melanomas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Posttranscriptional regulation of c-myc proto-oncogene expression and growth inhibition by recombinant human interferon-beta ser17 in a human colon carcinoma cell line

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

The prognostic significance of c-myc oncogene expression in uveal melanoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1772437

Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study

26 September 2018

1 reference

12 December 2020

Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha

1 reference

12 December 2020

Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma

1 reference

12 December 2020

Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells

1 reference

12 December 2020

Survival of patients with metastases from uveal melanoma

1 reference

12 December 2020

Overexpression of p53 is a late event in the development of malignant melanoma

1 reference

12 December 2020

C-myc oncogene expression in human melanoma and its relationship with tumour antigenicity

1 reference

12 December 2020

The clinical significance of oncogene expression in subungual melanoma

1 reference

12 December 2020

Inverse correlation between expression of HLA-B and c-myc in uveal melanoma

1 reference

12 December 2020

BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy

1 reference

12 December 2020

The ex vivo chemosensitivity profile of choroidal melanoma

1 reference

12 December 2020

Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma

1 reference

12 December 2020

Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma

1 reference

12 December 2020

Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group

1 reference

12 December 2020

The treatment of metastatic uveal melanoma

1 reference

12 December 2020

Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma

1 reference

12 December 2020

Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.2003.033498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

release_3kqvwzf6jbgtpht3j6lg76ee3i

5 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3kqvwzf6jbgtpht3j6lg76ee3i

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15548813%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

15548813

1 reference